

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Appropriate antibiotic management of bacterial... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1121/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1121" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Appropriate antibiotic management of bacterial lower respiratory tract infections" />
    
            <meta name="og:title" content="F1000Research Article: Appropriate antibiotic management of bacterial lower respiratory tract infections.">
            <meta name="og:description" content="Read the latest article version by Charles Feldman, Guy Richards, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="15478">
            <meta name="article-id" content="14226">
            <meta name="dc.title" content="Appropriate antibiotic management of bacterial lower respiratory tract infections">
            <meta name="dc.description" content="Lower respiratory tract infections are the leading cause of infectious disease deaths worldwide and are the fifth leading cause of death overall. This is despite conditions such as pneumococcal infections and influenza being largely preventable with the use of appropriate vaccines. The mainstay of treatment for the most important bacterial lower respiratory tract infections, namely acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and community-acquired pneumonia (CAP), is the use of antibiotics. Yet despite a number of recent publications, including clinical studies as well as several systematic literature reviews and meta-analyses, there is considerable ongoing controversy as to what the most appropriate antibiotics are for the empiric therapy of CAP in the different settings (outpatient, inpatient, and intensive care unit). Furthermore, in the case of AECOPD, there is a need for consideration of which of these exacerbations actually need antibiotic treatment. This article describes these issues and makes suggestions for appropriately managing these conditions, in the setting of the need for antimicrobial stewardship initiatives designed to slow current emerging rates of antibiotic resistance, while improving patient outcomes.">
            <meta name="dc.subject" content="antibiotics, chronic obstructive pulmonary disease, community-acquired pneumonia, antimicrobial stewardship  ">
            <meta name="dc.creator" content="Feldman, Charles">
            <meta name="dc.creator" content="Richards, Guy">
            <meta name="dc.date" content="2018/07/23">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14226.1">
            <meta name="dc.source" content="F1000Research 2018 7:1121">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="antibiotics">
            <meta name="prism.keyword" content="chronic obstructive pulmonary disease">
            <meta name="prism.keyword" content="community-acquired pneumonia">
            <meta name="prism.keyword" content="antimicrobial stewardship  ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/07/23">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1121">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14226.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1121">
            <meta name="citation_title" content="Appropriate antibiotic management of bacterial lower respiratory tract infections">
            <meta name="citation_abstract" content="Lower respiratory tract infections are the leading cause of infectious disease deaths worldwide and are the fifth leading cause of death overall. This is despite conditions such as pneumococcal infections and influenza being largely preventable with the use of appropriate vaccines. The mainstay of treatment for the most important bacterial lower respiratory tract infections, namely acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and community-acquired pneumonia (CAP), is the use of antibiotics. Yet despite a number of recent publications, including clinical studies as well as several systematic literature reviews and meta-analyses, there is considerable ongoing controversy as to what the most appropriate antibiotics are for the empiric therapy of CAP in the different settings (outpatient, inpatient, and intensive care unit). Furthermore, in the case of AECOPD, there is a need for consideration of which of these exacerbations actually need antibiotic treatment. This article describes these issues and makes suggestions for appropriately managing these conditions, in the setting of the need for antimicrobial stewardship initiatives designed to slow current emerging rates of antibiotic resistance, while improving patient outcomes.">
            <meta name="citation_description" content="Lower respiratory tract infections are the leading cause of infectious disease deaths worldwide and are the fifth leading cause of death overall. This is despite conditions such as pneumococcal infections and influenza being largely preventable with the use of appropriate vaccines. The mainstay of treatment for the most important bacterial lower respiratory tract infections, namely acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and community-acquired pneumonia (CAP), is the use of antibiotics. Yet despite a number of recent publications, including clinical studies as well as several systematic literature reviews and meta-analyses, there is considerable ongoing controversy as to what the most appropriate antibiotics are for the empiric therapy of CAP in the different settings (outpatient, inpatient, and intensive care unit). Furthermore, in the case of AECOPD, there is a need for consideration of which of these exacerbations actually need antibiotic treatment. This article describes these issues and makes suggestions for appropriately managing these conditions, in the setting of the need for antimicrobial stewardship initiatives designed to slow current emerging rates of antibiotic resistance, while improving patient outcomes.">
            <meta name="citation_keywords" content="antibiotics, chronic obstructive pulmonary disease, community-acquired pneumonia, antimicrobial stewardship  ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Charles Feldman">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa">
            <meta name="citation_author" content="Guy Richards">
            <meta name="citation_author_institution" content="Division of Critical Care, Charlotte Maxeke Johannesburg Academic Hospital, and Faculty of Health Sciences, University of Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa">
            <meta name="citation_publication_date" content="2018/07/23">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1121">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14226.1">
            <meta name="citation_firstpage" content="1121">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1121/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1121.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=15478 /> <input type=hidden id=articleId name=articleId value=14226 /> <input type=hidden id=xmlUrl value="/articles/7-1121/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1121-v1.xml"> <input type=hidden id=article_uuid value=a0795424-ed12-4c87-903d-feecdb455b4c /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Appropriate antibiotic management of bacterial lower respiratory tract infections"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14226.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14226.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1121"
  },
  "headline": "Appropriate antibiotic management of bacterial lower respiratory tract infections",
  "datePublished": "2018-07-23T11:41:49",
  "dateModified": "2018-07-23T11:41:49",
  "author": [
    {
      "@type": "Person",
      "name": "Charles Feldman"
    },    {
      "@type": "Person",
      "name": "Guy Richards"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Lower respiratory tract infections are the leading cause of infectious disease deaths worldwide and are the fifth leading cause of death overall. This is despite conditions such as pneumococcal infections and influenza being largely preventable with the use of appropriate vaccines. The mainstay of treatment for the most important bacterial lower respiratory tract infections, namely acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and community-acquired pneumonia (CAP), is the use of antibiotics. Yet despite a number of recent publications, including clinical studies as well as several systematic literature reviews and meta-analyses, there is considerable ongoing controversy as to what the most appropriate antibiotics are for the empiric therapy of CAP in the different settings (outpatient, inpatient, and intensive care unit). Furthermore, in the case of AECOPD, there is a need for consideration of which of these exacerbations actually need antibiotic treatment. This article describes these issues and makes suggestions for appropriately managing these conditions, in the setting of the need for antimicrobial stewardship initiatives designed to slow current emerging rates of antibiotic resistance, while improving patient outcomes."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1121/v1",
            "name": "Appropriate antibiotic management of bacterial lower respiratory tract..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Appropriate antibiotic management of bacterial lower respiratory tract... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=15478 data-id=14226 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14226.1" data-recommended="" data-doi="10.12688/f1000research.14226.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1121/v1/pdf?article_uuid=a0795424-ed12-4c87-903d-feecdb455b4c" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14226-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14226-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14226-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Feldman C and Richards G. Appropriate antibiotic management of bacterial lower respiratory tract infections [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1121 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14226.1" target=_blank>https://doi.org/10.12688/f1000research.14226.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14226-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14226 id=track-article-signin-14226 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14226?target=/articles/7-1121/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15478 /> <input name=articleId type=hidden value=14226 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Appropriate antibiotic management of bacterial lower respiratory tract infections</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:feldmanc@medicine.wits.ac.za" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Charles Feldman</span></a><a href="https://orcid.org/0000-0002-6881-8314" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6881-8314</div><sup>1</sup>,&nbsp;</span><span class="">Guy Richards<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:feldmanc@medicine.wits.ac.za" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Charles Feldman</span></a><a href="http://orcid.org/0000-0002-6881-8314" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6881-8314</div><sup>1</sup>,&nbsp;</span><span class="">Guy Richards<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 23 Jul 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14226.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa<br/> <sup>2</sup> Division of Critical Care, Charlotte Maxeke Johannesburg Academic Hospital, and Faculty of Health Sciences, University of Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa<br/> <p> <div class=margin-bottom> Charles Feldman <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Guy Richards <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=36652-36130></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=36653-36129></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Lower respiratory tract infections are the leading cause of infectious disease deaths worldwide and are the fifth leading cause of death overall. This is despite conditions such as pneumococcal infections and influenza being largely preventable with the use of appropriate vaccines. The mainstay of treatment for the most important bacterial lower respiratory tract infections, namely acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and community-acquired pneumonia (CAP), is the use of antibiotics. Yet despite a number of recent publications, including clinical studies as well as several systematic literature reviews and meta-analyses, there is considerable ongoing controversy as to what the most appropriate antibiotics are for the empiric therapy of CAP in the different settings (outpatient, inpatient, and intensive care unit). Furthermore, in the case of AECOPD, there is a need for consideration of which of these exacerbations actually need antibiotic treatment. This article describes these issues and makes suggestions for appropriately managing these conditions, in the setting of the need for antimicrobial stewardship initiatives designed to slow current emerging rates of antibiotic resistance, while improving patient outcomes. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> antibiotics, chronic obstructive pulmonary disease, community-acquired pneumonia, antimicrobial stewardship </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Charles Feldman (<a href="mailto:feldmanc@medicine.wits.ac.za">feldmanc@medicine.wits.ac.za</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Charles Feldman </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> CF has received honoraria for acting on the advisory board or speaker’s bureau of pharmaceutical companies manufacturing or marketing macrolide antibiotics (Abbott, Aspen, Cipla, Pfizer, and Sandoz). GR has received honoraria for acting on the speaker’s bureau of companies manufacturing or marketing antibiotics (Aspen and Bayer). </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Feldman C and Richards G. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Feldman C and Richards G. Appropriate antibiotic management of bacterial lower respiratory tract infections [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1121 (<a href="https://doi.org/10.12688/f1000research.14226.1" target=_blank>https://doi.org/10.12688/f1000research.14226.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 23 Jul 2018, <b>7</b>(F1000 Faculty Rev):1121 (<a href="https://doi.org/10.12688/f1000research.14226.1" target=_blank>https://doi.org/10.12688/f1000research.14226.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 23 Jul 2018, <b>7</b>(F1000 Faculty Rev):1121 (<a href="https://doi.org/10.12688/f1000research.14226.1" target=_blank>https://doi.org/10.12688/f1000research.14226.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d22208e159>Introduction</h2><p class="" id=d22208e162>Lower respiratory tract infections (LRTIs), which generally are considered to include acute bronchitis, bronchiolitis, influenza, and pneumonia, are a significant cause of morbidity and mortality in patients worldwide<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup>. The Global Burden of Disease Study evaluated evidence for the global, regional, and national morbidity and mortality of LRTIs and indicated that, for 2015, LRTIs were the leading infectious disease cause of death and the fifth leading cause of death overall<sup><a href="#ref-3">3</a></sup>. They estimated that LRTIs caused 2.74 million deaths and 103.0 million disability-adjusted life years (DALYs). While the burden had decreased in children younger than 5 years of age, it had increased in many regions for individuals older than 70 years. The study specifically investigated four etiologies—two bacterial and two viral—and noted that pneumococcal pneumonia was the most common etiology, which led to 1,517,388 deaths or 55.4% of LRTI deaths in all ages. Pneumococcal pneumonia was also a cause of a significant number of deaths in the elderly population worldwide (693,041 deaths in adults at least 70 years old). LRTIs are largely preventable causes of death, as vaccines are available against both influenza and pneumococcal pneumonia. Furthermore, while antiviral therapy is available for the treatment of influenza infections once they occur, the mainstay of treatment for community-acquired pneumonia (CAP) and acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD), which are the focus of this overview of the recent literature, is the use of antibiotics.</p><p class="" id=d22208e176>Overuse of antibiotics both in and out of hospital has resulted in an exponential increase in resistance globally. This has, and will, impact upon the ability to treat infections and be directly associated with increasing morbidity and mortality<sup><a href="#ref-4">4</a>,<a href="#ref-5">5</a></sup>. This has resulted in numerous antimicrobial stewardship (AMS) programs—both in South Africa and internationally—designed to slow the rate at which organisms develop resistance and at the same time improve outcomes<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. AMS programs consist of two major pillars: first, infection prevention and control and then appropriate use of antibiotics, the latter of which will be the focus of this article. Appropriate use implies the correct indication, dose, duration, and administration method (that is, according to pharmacokinetic principles).</p><p class="" id=d22208e193>The actual antibiotic choice for bacterial LRTIs depends upon the likely organism; however, it is recognized that distinguishing viral from bacterial infections, both in CAP and in acute exacerbations of COPD, and recognizing non-infective COPD exacerbations are not always clear-cut processes. In fact, as many as 60% of COPD exacerbations may be due to viral infections, in particular rhinovirus, and in winter the influenza virus, and there is an increasing recognition of the important role for viruses in the etiology of CAP<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>.</p><p class="" id=d22208e203>Although they are beyond the scope of this article, a brief review of biomarkers and the role they may play in the decision regarding the need for initiation, discontinuation, or duration of antibiotic treatment are of interest. Of the various biomarkers described, perhaps the most studied are C-reactive protein (CRP) and procalcitonin (PCT). One systematic review and meta-analysis evaluated the use of CRP to guide antibiotic therapy in patients presenting to primary care with symptoms of acute respiratory infections and reported a significant reduction in antibiotic use with a slight increase in hospital admissions<sup><a href="#ref-10">10</a></sup>. The European guideline on LRTIs indicates that out of the hospital setting, where chest radiographic confirmation of CAP is usually not available, a measurement of CRP in a patient suspected of having CAP can be performed (a point-of-care test is currently available)<sup><a href="#ref-11">11</a></sup>. They recommend that a level of less than 20 mg/L at presentation, in the presence of symptoms for at least 24 hours, makes pneumonia highly unlikely but that a level of more than 100 mg/L makes pneumonia likely.</p><p class="" id=d22208e215>With regard to PCT, there are some differences in the conclusions reached in the various studies. One systematic review and meta-analysis assessed the safety and efficacy of PCT for starting and stopping antibiotics in a range of patients with varying severity of acute respiratory tract infections in different clinical settings<sup><a href="#ref-12">12</a></sup>. The authors concluded that the use of PCT to guide initiation and duration of antibiotic treatment was associated with a lower risk of mortality, lower antibiotic consumption, and lower risk of antibiotic side effects. The authors, when using a patient-level meta-analysis, reached similar conclusions<sup><a href="#ref-13">13</a></sup>. However, a recent study of PCT-guided use of antibiotics in the treatment of patients with suspected LRTIs did not result in less use of antibiotics than did usual care<sup><a href="#ref-14">14</a></sup>. Furthermore, there is no point-of-care test available for the measurement of PCT, which is also costly.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22208e233>Antibiotic treatment of community-acquired pneumonia</h2><p class="" id=d22208e236>Antibiotics are the mainstay of therapy for CAP, and the initial antibiotic treatment needs to be empiric, as the causative organism or organisms are unknown at the time of presentation. However, there has been ongoing debate over a considerable period of time as to the most appropriate choice of initial empiric antibiotic treatment in the different settings: outpatient, inpatient, and intensive care unit (ICU). A number of national and international guidelines, which describe the appropriate management of CAP, have been developed; some of these have been updated recently or are in the process of being updated<sup><a href="#ref-11">11</a>,<a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. It is clear when evaluating the guidelines that differences exist with regard to the various recommendations, including those for initial empiric antibiotic therapy<sup><a href="#ref-11">11</a>,<a href="#ref-15">15</a>–<a href="#ref-17">17</a></sup>.</p><p class="" id=d22208e259>For outpatient antibiotic therapy of CAP, the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guideline recommends a macrolide or tetracycline for previously healthy patients with no risk factors for drug-resistant <i>Streptococcus pneumoniae</i> (DRSP) infections. Furthermore, a respiratory fluoroquinolone or a beta-lactam plus a macrolide is recommended in the presence of certain comorbidities or risk factors for DRSP infections<sup><a href="#ref-15">15</a></sup>. This is in contrast with the European guideline, which recommends amoxicillin or tetracycline for outpatient use with a macrolide or tetracycline being used only in the case of penicillin allergy, in settings with low levels of pneumococcal macrolide resistance<sup><a href="#ref-11">11</a></sup>. Similarly, the South African guideline recommends amoxicillin as the treatment of choice, and a macrolide is to be used in the case of penicillin allergy in settings with low levels of pneumococcal macrolide resistance and other options are reserved for the elderly or for those with comorbidities or recent antibiotic use or both<sup><a href="#ref-16">16</a></sup>. A recent literature review from Europe described the etiology and management of CAP in adults, which included both primary care and hospitalized cases<sup><a href="#ref-18">18</a></sup>. The authors noted differences in antibiotic prescribing habits in the various regions of Europe. Beta-lactams were the most commonly prescribed class of antibiotics, and monotherapy was more common than combination therapy, but hospitalized patients more commonly received combination therapy than did outpatients. These differences in antibiotic recommendations could be ascribed to differences in the microbial etiology of CAP in the different regions, differences in the prevalence of antibiotic-resistant pathogens, differing patient populations, differences in national guideline recommendations, and other local factors, including regulatory requirements. A recent Cochrane review concluded that there was insufficient evidence from randomized controlled trials to make evidence-based recommendations regarding appropriate treatment in adult outpatients with CAP<sup><a href="#ref-19">19</a></sup>. Owing to the low number of studies comparing the same antibiotic pairs, pooling of the data was also not possible; in general, the individual studies did not suggest any significant differences in the efficacy of the various antibiotics studied.</p><p class="" id=d22208e286>For inpatients with CAP, the IDSA/ATS guideline recommends the use of either a beta-lactam-macrolide combination or fluoroquinolone monotherapy for non-critically ill cases<sup><a href="#ref-15">15</a></sup>; the European and South African guidelines have the addition of a macrolide to the beta-lactam as an option<sup><a href="#ref-11">11</a>,<a href="#ref-16">16</a></sup>. Most of the guidelines recommend a combination therapy of a beta-lactam and macrolide or fluoroquinolone in those requiring ICU admission, and additional options are for possible pseudomonal infection<sup><a href="#ref-11">11</a>,<a href="#ref-15">15</a>,<a href="#ref-16">16</a>,<a href="#ref-20">20</a></sup>. The most controversial area has been whether the use of a macrolide antibiotic should be an obligatory component of initial antibiotic treatment<sup><a href="#ref-21">21</a></sup>. Earlier studies of hospitalized patients with moderately severe pneumonia suggested that beta-lactam monotherapy was not inferior to beta-lactam–macrolide combination therapy<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. However, as has been indicated by several investigators, those studies had certain limitations that make it difficult to accept their conclusions<sup><a href="#ref-20">20</a>,<a href="#ref-21">21</a></sup>. A recent review highlighted all the studies documenting a benefit of combination therapy among inpatients; most of these studies were among CAP patients hospitalized in the ward and not the ICU<sup><a href="#ref-17">17</a></sup>. Furthermore, Okumura <i>et al.</i> documented that in hospitalized CAP patients at low risk of drug-resistant pathogens, beta-lactam–macrolide combination treatment lowered 30-day mortality compared with beta-lactam therapy alone: adjusted odds ratio (OR) 0.28, 95% confidence interval (CI) 0.09–0.87<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d22208e343>There may still be some debate as to the need for adding a macrolide in less severely ill hospitalized cases. However, two matched case-control studies were published by the CAPUCI II Consortium on severe CAP patients admitted to the ICU<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. In the first, Gattarello <i>et al.</i> compared the outcome of two cohorts of critically ill patients with pneumococcal CAP from different time periods (2001–2002 and 2008–2013)<sup><a href="#ref-25">25</a></sup>. The investigators noted that the mortality rate decreased by 18% from the earlier to the later cohort (together with other outcome benefits). This was determined on multivariate analysis to be associated with giving of the first dose of antibiotic within 3 hours (OR 0.36, 95% CI 0.15–0.87) and to the use of combination therapy (OR 0.19, 95% CI 0.07–0.51), which occurred more commonly in the second time period. The most frequently used antibiotic regimen was the combination of a cephalosporin with a macrolide, but other combinations included a cephalosporin and a fluoroquinolone. The second study was on patients with severe non-pneumococcal CAP, and the results were essentially similar<sup><a href="#ref-26">26</a></sup>. Once again, the most commonly used antibiotic regimen was a cephalosporin and a macrolide. Early antibiotic treatment (OR 0.07, 95% CI 0.02–0.22) and combined antibiotic therapy (OR 0.23, 95% CI 0.07–0.74), which occurred more commonly in the second time period, were independently associated with a lower ICU mortality.</p><p class="" id=d22208e365>Whereas a few studies have documented that combination therapy with a beta-lactam and a macrolide or fluoroquinolone has no additional benefit in critically ill patients with CAP<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>, several recent studies have confirmed the benefit of combination therapy in this situation<sup><a href="#ref-29">29</a>–<a href="#ref-31">31</a></sup>. For example, Pereira <i>et al.</i> documented that combination antibiotic therapy together with a macrolide was independently associated with a reduction in hospital stay (OR 0.17, 95% CI 0.06–0.51) and 6-month mortality (OR 0.21, 95% CI 0.07–0.57)<sup><a href="#ref-31">31</a></sup>.</p><p class="" id=d22208e389>With regard to systematic reviews and meta-analyses of antibiotic therapy in critically ill patients with CAP, an early study concluded that there was a significant reduction in mortality when macrolides were used as part of treatment: 21% (836/4,036) versus 24% (1,369/5,814), risk ratio 0.82, 95% CI 0.70–0.97, <i>p</i> = 0.02<sup><a href="#ref-32">32</a></sup>. When macrolide monotherapy was excluded, the mortality benefit of macrolides was still maintained. There was a trend towards better mortality with beta-lactam–macrolide therapy compared with beta-lactam–fluoroquinolone therapy: mortality with beta-lactam–macrolide therapy 20% (511/2,561 patients) versus 23% (386/1,680) with beta-lactam–fluoroquinolone therapy (risk ratio 0.83, 95% CI 0.67–1.03, <i>p</i> = 0.09)<sup><a href="#ref-32">32</a></sup>. A number of more recent systematic reviews of antibiotic therapy in patients with CAP have been undertaken. Some that did not restrict the study to severely ill cases documented no benefit on 30-day mortality of beta-lactam–macrolide or beta-lactam–fluoroquinolone combination therapies over fluoroquinolone monotherapy<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. However, Horita <i>et al.</i> concluded that, compared with beta-lactam monotherapy, combination therapy with a beta-lactam plus macrolide may decrease all-cause mortality only in severe CAP<sup><a href="#ref-35">35</a></sup>. The authors did recommend caution in this interpretation, as the conclusion was based mainly on observational studies. Lastly, Lee <i>et al.</i>, in their systematic review and meta-analysis of patients with severe CAP, noted that the overall mortality of the beta-lactam–macrolide group was lower than that of the beta-lactam–fluoroquinolone group (19.4% versus 26.8%) (OR 0.68, 95% CI 0.49–0.94)<sup><a href="#ref-36">36</a></sup>. Furthermore, length of hospital stay was shorter in the former group compared with the latter group, although there was no difference in length of ICU stay. However, despite these positive findings, the authors did indicate the need for caution with the conclusions because of the high risk of bias in the trials and methodological limitations.</p><p class="" id=d22208e428>The reason for the potential benefit of macrolide combination therapy in patients with CAP is unclear, but it is known that macrolide antibiotics have additional anti-inflammatory, immunomodulatory effects and do not directly lyse bacteria, which may play an important role. In the case of the pneumococcal infections, for example, lytic antibiotics increase the release of the pro-inflammatory toxin pneumolysin as well as cell-wall components, which may be associated with host tissue injury<sup><a href="#ref-37">37</a></sup>. For this reason, other investigators have studied the timing of combination antibiotic treatment<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. Such investigators have theorized that administering macrolides some time prior to the beta-lactam agent may improve patient outcomes because of the anti-inflammatory effects that attenuate the inflammatory response initiated by the beta-lactam-induced lysis of bacteria. Metersky <i>et al.</i> undertook a retrospective cohort study using electronic health records from a large database, comparing the outcome of CAP cases receiving a macrolide 1 hour before a cephalosporin compared with cases receiving a cephalosporin 1 hour before the macrolide<sup><a href="#ref-38">38</a></sup>. The adjusted mortality was about 30% lower in the former group compared with the latter group, although this did not reach statistical significance. There were also trends towards lower combined in-hospital mortality/hospice discharge and reduced length of stay. The authors concluded that it was worth pursuing this investigation with a larger cohort and perhaps in subsets of severe pneumonia cases. Furthermore, Peyrani <i>et al.</i> undertook a secondary analysis of data from the Community-Acquired Pneumonia Organisation (CAPO) database<sup><a href="#ref-39">39</a></sup>. They documented that, in CAP cases in whom a macrolide had been administered before the beta-lactam, compared with the reverse, the time to clinical stability (3 versus 4 days, <i>p</i> = 0.011), length of hospital stay (6 versus 7 days, <i>p</i> = 0.002) and mortality (3% versus 7.2%, <i>p</i> = 0.228) were lower.</p><p class="" id=d22208e466>Based on the findings of the majority of the studies, and in line with the recommendations of other investigators<sup><a href="#ref-21">21</a></sup>, we would recommend that a combination of a beta-lactam and a macrolide be used in hospitalized and severely ill cases with CAP and that the macrolide be given prior to initiation of the beta-lactam. Furthermore, the antibiotics should be started as soon as possible after confirmation of the diagnosis of CAP. With regard to the fluoroquinolones, careful consideration needs to be given to their routine use for suspected CAP in areas in which tuberculosis (TB) is endemic because it is frequently difficult to clinically differentiate TB from CAP on initial presentation of patients<sup><a href="#ref-40">40</a></sup>. Therefore, there is concern that the use of fluoroquinolone in someone with TB but suspected of having CAP may lead to a delay in the diagnosis of TB and, moreover, be associated with the development of drug-resistant TB<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. Clearly, the above discussion has focused on empiric antibiotic therapy, and once the results of microbiological testing become available, antibiotic treatment should be tailored appropriately to the findings.</p><p class="" id=d22208e484>Two additional aspects of antibiotic therapy in patients with CAP need mention. The first is the importance of time to initiation/administration of antibiotics relative to the time of presentation with CAP. Although there has been the odd study suggesting that time to initiation of antibiotics has no impact on various patient outcomes<sup><a href="#ref-42">42</a></sup>, this contention is not supported by the majority of additional studies<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a>,<a href="#ref-43">43</a>,<a href="#ref-44">44</a></sup>. All of the studies from the CAPUCI II Consortium of critically ill patients with CAP indicated that early antibiotic administration (&lt;3 hours) was independently associated with a lower ICU mortality<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a>,<a href="#ref-43">43</a></sup>. An additional study of hospitalized patients with CAP indicated that delay of the first dose of antibiotics beyond 4 hours was one of the independent predictors of mortality (adjusted OR 3.9)<sup><a href="#ref-44">44</a></sup>. Furthermore, the systematic review by Lee <i>et al.</i><sup><a href="#ref-34">34</a></sup>, assessing three aspects of antibiotic therapy in hospitalized patients with CAP, noted that administration of antibiotics within 4 to 8 hours of hospital arrival was associated with a reduction in mortality, although the quality of evidence was assessed as being relatively poor. Thus, while it is clear that patients with severe CAP (especially those with septic shock) should receive antibiotics as soon as possible<sup><a href="#ref-20">20</a></sup>, the impact of time to antibiotic initiation on outcome in less severely ill cases is not clear<sup><a href="#ref-20">20</a></sup>. It seems prudent to initiate antibiotics as soon as possible in patients suspected of having CAP; however, it should not be at the expense of an adequate consideration of possible alternative diagnoses, including acute bronchitis, influenza, pulmonary embolism, and heart failure<sup><a href="#ref-20">20</a></sup>. In such patients, administration of an antibiotic would have no benefit, would be associated with potentially serious consequences, and would be contrary to AMS initiatives.</p><p class="" id=d22208e537>Lastly, some consideration should be given to the appropriate duration of antibiotic therapy for patients with CAP which has varied over time, even though earlier studies and even two meta-analyses indicated that shorter duration of therapy (for example, 7 days or less) could be safely and effectively used in patients with mild to moderately severe pneumonia<sup><a href="#ref-45">45</a></sup>. One recent multicenter non-inferiority randomized controlled trial of hospitalized patients with CAP randomly assigned patients at day 5 to an intervention or to a control group. The former were treated with antibiotics for a minimum of 5 days, and the antibiotic was stopped when the temperature had been 37.8°C or less for 48 hours and the patients had no more than one CAP-associated sign of clinical instability (this being in line with the recommendation of the IDSA/ATS guideline on CAP management)<sup><a href="#ref-46">46</a></sup>. The antibiotic treatment in the control group of patients was determined by the individual patient’s physician. The results demonstrated non-inferiority of the shorter antibiotic course and supported the IDSA/ATS recommendations. In terms of potential limitations of the study, 60% of the patients were in low Pneumonia Severity Index (PSI) risk groups I–III and had a predicted mortality of less than 1%, and also there was a low rate of comorbid illnesses in the study population, which would limit generalizability to patients with significant comorbidity.</p><p class="" id=d22208e549>However, conversely, a more recent multicenter, non-inferiority, randomized controlled trial was undertaken in hospitalized CAP patients who had reached clinical stability within 5 days of hospitalization, who were randomly assigned to a standard or individualized group<sup><a href="#ref-47">47</a></sup>. The latter had antibiotics discontinued 48 hours after reaching clinical stability, having had at least 5 days of antibiotics. The study was stopped early because of apparent inferiority of the individualized treatment over the standard treatment with regard to the primary outcome, which was early failure within 30 days. This difference (11.2% in the individualized group versus 7.4% in the standard group) was not statistically significant, but the safety committee interrupted the study because at the time this was the first study to evaluate clinical stability as a proxy to shorten antibiotic exposure in patients hospitalized with CAP and the 30-day mortality was higher in the individualized versus the standard group.</p><p class="" id=d22208e556>However, other studies and reviews have supported shorter duration of antibiotic therapy in patients with CAP and suggested that the use of biomarkers, such as PCT, may be useful in guiding both the initiation and the duration of antibiotic treatment<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. One group of investigators documented that an implementation strategy, tailored to identify previous barriers to early switch, was associated with a reduced duration of intravenous therapy<sup><a href="#ref-50">50</a></sup>. Another implemented a dedicated CAP team to manage low-risk, hospitalized CAP patients, which resulted in a reduced hospital length of stay, time to switch from intravenous antibiotics, and antibiotic duration without any adverse events<sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d22208e574>It is interesting to briefly mention non-antibiotic adjunctive therapies, which—though clearly beyond the scope of this review—continue to be evaluated in critically ill patients with CAP, in whom the mortality remains high despite apparently appropriate antibiotic treatment. A number of such therapies have been studied, of which the use of corticosteroids (CSs) appears to be most promising, and a number of positive randomized controlled trials and systematic literature reviews have been published in recent years<sup><a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. Most recently, the Cochrane database of systematic reviews updated its 2011 review of randomized controlled trials of systemic CS therapy, as adjunct to antibiotic therapy versus placebo or no CS, and concluded that CS therapy significantly reduces morbidity (various end-points) and mortality (relative risk 0.58, 95% CI 0.40–0.84) in adults with severe CAP; the number needed to treat for additional beneficial outcome was 18 patients (95% CI 12–49) to prevent one death<sup><a href="#ref-54">54</a></sup>. CSs also significantly reduced morbidity, but not mortality, for non-severe CAP in adults, and although there were more adverse events in the CS group (especially hyperglycemia), the harms did not outweigh the benefits. The South African CAP guideline makes some specific recommendations for the use of CSs in patients with severe CAP<sup><a href="#ref-16">16</a></sup>, and it would seem likely that as the older CAP guidelines are updated, more specific recommendations regarding adjunctive therapy for CAP will be included.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22208e595>Antibiotics for acute exacerbations of chronic obstructive pulmonary disease</h2><p class="" id=d22208e598>Antibiotics are used in two instances in COPD: in order to treat an infection associated with an acute exacerbation (acute exacerbations of COPD [AECOPD]) and for prophylaxis. We have previously described a treatment algorithm designed to limit antibiotic use and assist clinicians in the outpatient setting. This algorithm was based upon severity of symptoms according to the Anthonisen criteria and point-of-care testing using the CRP where the clinical criteria are equivocal regarding severity<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. Although the study by Anthonisen <i>et al.</i><sup><a href="#ref-56">56</a></sup> is old, various other studies have confirmed the value of antibiotics, particularly in the severe exacerbation; however, perhaps the most important of these criteria is sputum purulence and, as mentioned above, the presence of an elevated CRP<sup><a href="#ref-55">55</a>,<a href="#ref-57">57</a>–<a href="#ref-60">60</a></sup> (<a href="#f1">Figure 1</a>). In addition, more recently, a meta-analysis that included four trials and 679 patients found that the use of PCT significantly reduced antibiotic use with an OR of 0.26 (95% CI 0.14–0.50, <i>p</i> &lt;0.0001) without increasing clinical failure and mortality<sup><a href="#ref-61">61</a></sup>. Readmission rates and subsequent exacerbations were similar in the two groups. As discussed previously, a reduction of antibiotic use is a critical component of AMS.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/15478/c3a5e9fd-f3f3-4c70-b507-99de4b1e9910_figure1.gif"><img alt="c3a5e9fd-f3f3-4c70-b507-99de4b1e9910_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/15478/c3a5e9fd-f3f3-4c70-b507-99de4b1e9910_figure1.gif"></a><div class=caption><h3>Figure 1. Recommendations for antibiotic use in non-hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease.</h3><p id=d22208e645>COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; POCT, point-of-care testing. Reproduced with permission from the <i>South African Medical Journal</i><sup><a href="#ref-41">41</a></sup>.</p></div></div><p class="" id=d22208e658>The most common bacterial organisms isolated in AECOPD remain <i>Haemophilus influenzae</i> and <i>S. pneumoniae</i>; however, <i>Moraxella catarrhalis</i> and the atypical organisms may also be seen<sup><a href="#ref-62">62</a></sup>. Viral infections may predispose patients to bacterial infections, and the specific bacteria isolated depend on factors such as age of more than 65 years, steroid use, comorbid illness such as cardiac disease, structural lung disease, or more severe COPD—Global Initiative for Chronic Obstructive Lung Disease (GOLD) 3–4 lung functions—and previous antibiotic use in the past 3 months (as would be the case in frequent exacerbators)<sup><a href="#ref-63">63</a>–<a href="#ref-65">65</a></sup>. In fact, some studies indicate that more resistant organisms such as <i>Klebsiella pneumoniae</i>, <i>Staphylococcus aureus</i>, <i>Pseudomonas aeruginosa</i>, <i>Escherichia coli</i>, and <i>Acinetobacter</i> and <i>Enterobacter</i> species are increasingly being seen, particularly in developing countries, even without these risk factors<sup><a href="#ref-66">66</a>–<a href="#ref-69">69</a></sup>. This implies that the choice of agent depends on both risk factors and local epidemiology. However, we would recommend that therapy be initiated with <i>H. influenzae</i> and <i>S. pneumoniae</i> in mind<sup><a href="#ref-70">70</a></sup>.</p><p class="" id=d22208e718>As such, the initial antibiotic choice would be amoxicillin (or amoxicillin–clavulanate where beta-lactamase production by <i>H. influenzae</i> is prevalent) or a fluoroquinolone. However, the US Food and Drug Administration has recommended that the latter be used only as a last resort agent and be reserved for use in patients who have no other treatment options because of both side effects and potential collateral damage<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d22208e729>Other agents, such as the cephalosporins cefuroxime or cefpodoxime, may be appropriate as they are active against <i>H. influenzae</i> and higher doses would also be effective against the pneumococcus. The extended-spectrum macrolides may be effective against the former but increasing resistance of the pneumococcus has limited their utility. For hospitalized patients with risks for pseudomonas or other more-resistant organisms, anti-pseudomonal agents such as piperacillin–tazobactam, cefepime, or ciprofloxacin may be considered. It is recommended that these patients have a sputum culture performed on admission<sup><a href="#ref-72">72</a></sup>.</p><p class="" id=d22208e739>The duration of the antibiotic “course” has been somewhat controversial in that, for a long time, there has been a mistaken belief that longer courses decrease resistance and improve outcome. This is patently untrue, and in many diseases (including COPD) shorter courses have had equivalent outcomes with fewer adverse events<sup><a href="#ref-73">73</a></sup>. As such, we would recommend 5 days as being the optimal duration for most AECOPD<sup><a href="#ref-74">74</a>–<a href="#ref-76">76</a></sup>.</p><p class="" id=d22208e753>The dosing of each antibiotic should be according to pharmacokinetic principles. The beta-lactams are time-dependent agents; as such, the target should be to exceed the minimum inhibitory concentration by as much time as possible, both to limit resistance and to improve outcome. The fluoroquinolones, as concentration-dependent agents, should preferably be administered once daily to achieve a maximal area under the inhibitory curve (AUIC) or an area under the curve-to-MIC ratio (AUC/MIC). Unfortunately, owing to toxicity issues, this is not possible with all agents in practice. For example, if an agent such as ciprofloxacin is going to be used, it must be administered twice daily because of suspected or documented infection with some of the Gram-negative pathogens described above<sup><a href="#ref-77">77</a>,<a href="#ref-78">78</a></sup>. The concept of “short-course high-dose antibiotic therapy” embodies these principles and should be employed wherever possible.</p><p class="" id=d22208e763>Of interest, established guidelines for the management of COPD exacerbations such as those of the GOLD initiative are generally not well adhered to and this includes antibiotic strategies. In a recent study evaluating compliance, 64 (68.1%) of the 94 patients received antibiotics, of which only 71.9% were appropriate<sup><a href="#ref-79">79</a></sup>.</p><p class="" id=d22208e770>Inhaled antibiotics have not been well evaluated; however, one study that used nebulized tobramycin twice daily for 14 days in patients with severe COPD colonized with multidrug-resistant <i>P. aeruginosa</i> demonstrated a 42% decrease in AECOPD compared with the previous 6 months and also a marked reduction in markers of inflammation, indicating a potential role for this modality of therapy<sup><a href="#ref-80">80</a></sup>.</p><p class="" id=d22208e780>An alternative use for antibiotics in patients with COPD has been prophylaxis for exacerbations, which are predictive of a worse outcome in COPD, and any means that might reduce them may potentially also improve long-term survival and quality of life<sup><a href="#ref-81">81</a></sup>. Numerous agents used for COPD have been shown to reduce exacerbations, and these include the long-acting antimuscarinic agents, inhaled CSs, and the phosphodiesterase 4 inhibitors. Antibiotics, specifically the macrolides, have also been shown to provide benefit; however, the exact mechanism has not been fully elucidated<sup><a href="#ref-82">82</a>–<a href="#ref-84">84</a></sup>. Different anti-inflammatory effects have been investigated <i>in vitro</i> but not proven <i>in vivo</i><sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>.</p><p class="" id=d22208e807>Doses vary, but the most frequent doses of azithromycin administered have been 250 or 500 mg three times a week. There are possible side effects from the use of these agents for this purpose, and these include resistance of bacteria and non-tuberculous mycobacteria, drug–drug interactions, QT prolongation, reversible deafness, and gastrointestinal upset<sup><a href="#ref-85">85</a></sup>. However, when used in selected patients, the macrolides are safe and cost effective<sup><a href="#ref-86">86</a>,<a href="#ref-87">87</a></sup>.</p><p class="" id=d22208e821>In line with stewardship principles, vaccination strategies, if effective, would be valuable in reducing antibiotic use. Whereas vaccination with the pneumococcal polysaccharide vaccine has provided inconsistent benefit in COPD, influenza vaccine—in particular, when combined with the pneumococcal polysaccharide vaccine (studies using the conjugate vaccine are not available but it would be expected to be better)—reduces hospitalization for pneumonia, death, death from influenza, and death from pneumonia<sup><a href="#ref-88">88</a></sup>. In addition, a meta-analysis of the use of an oral, whole-cell, non-typeable <i>H. influenzae</i> (NTHi) vaccine versus placebo in patients with AECOPD found a statistically significant 80% increase in antibiotic courses per person in the placebo group (risk ratio 1.81, 95% CI 1.35–2.44, <i>p</i> &lt;0.0001) was noted<sup><a href="#ref-89">89</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22208e841>Conclusions</h2><p class="" id=d22208e844>CAP and bacterial AECOPD are significant LRTIs associated with considerable morbidity and mortality. Despite numerous clinical studies as well as systematic reviews and meta-analyses, there is still ongoing debate as to the appropriate treatment of CAP, particularly in severely ill cases, and additionally which AECOPD actually need antibiotics. These issues are discussed in detail in the article, and recommendations are given on the basis of the authors’ collective experience. Furthermore, it is important to remember that, with regard to antibiotic use, these agents are a potentially life-saving resource that must be used wisely both in terms of the specific agent, duration, and dose and in the correct circumstances.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d22208e1 class=n-a></a><h2 class=main-title id=d22464>Competing interests</h2><p class=metadata-entry><a name=d22208e96 class=n-a></a><p id=d22208e97> CF has received honoraria for acting on the advisory board or speaker’s bureau of pharmaceutical companies manufacturing or marketing macrolide antibiotics (Abbott, Aspen, Cipla, Pfizer, and Sandoz). GR has received honoraria for acting on the speaker’s bureau of companies manufacturing or marketing antibiotics (Aspen and Bayer).</p></p></div><div class=back-section><a name=d22208e1 class=n-a></a><h2 class=main-title id=d22466>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d22208e851 class=n-a></a><h2 class=main-title id=d22208e853>Acknowledgements</h2><p class="" id=d22208e856>CF is supported by the National Research Foundation of South Africa.</p></div><div class=back-section><a name=d22208e860 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d22748>References</h2><div class="section ref-list"><a name=d22208e860 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d22208e867 class=n-a></a>Chapter 18. Acute lower respiratory infections. ERS White Book. (last accessed 20 February, 2018); 210–223. <a target=xrefwindow id=d22208e869 href="https://www.erswhitebook.org/files/public/Chapters/18_ALRIs.pdf">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d22208e878 class=n-a></a>Greene G, Hood K, Little P, <i> et al.</i>: Towards clinical definitions of lower respiratory tract infection (LRTI) for research and primary care practice in Europe: an international consensus study. <i>Prim Care Respir J.</i> 2011; <b>20</b>(3): 299–306, 6 p following 306. <a target=xrefwindow id=d22208e889 href="http://www.ncbi.nlm.nih.gov/pubmed/21509421">PubMed Abstract </a> | <a target=xrefwindow id=d22208e892 href="http://dx.doi.org/10.4104/pcrj.2011.00034">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729280930"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e901 class=n-a></a>GBD 2015 LRI Collaborators: Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. <i>Lancet Infect Dis.</i> 2017; <b>17</b>(11): 1133–61. <a target=xrefwindow id=d22208e909 href="http://www.ncbi.nlm.nih.gov/pubmed/28843578">PubMed Abstract </a> | <a target=xrefwindow id=d22208e912 href="http://dx.doi.org/10.1016/S1473-3099(17)30396-1">Publisher Full Text </a> | <a target=xrefwindow id=d22208e915 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5666185">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729280930">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d22208e928 class=n-a></a>Review on antimicrobial resistance: Tackling a global health crisis: Initial steps. 2015. (last accessed 27 February, 2018). <a target=xrefwindow id=d22208e930 href="https://amr-review.org/sites/default/files/Report-52.15.pdf">Reference Source</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d22208e939 class=n-a></a>Brink A, Feldman C, Richards G, <i> et al.</i>: Emergence of extensive drug resistance (XDR) among Gram-negative bacilli in South Africa looms nearer. <i>S Afr Med J.</i> 2008; <b>98</b>(8): 586, 588, 590 passim. <a target=xrefwindow id=d22208e950 href="http://www.ncbi.nlm.nih.gov/pubmed/18928032">PubMed Abstract </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d22208e960 class=n-a></a>Mission Statement of the South African Antibiotic Stewardship Programme. (last accessed 27 February, 2018). <a target=xrefwindow id=d22208e962 href="https://www.fidssa.co.za/SAASP">Reference Source</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d22208e971 class=n-a></a>UK recommendations for combating antimicrobial resistance: a review of ‘antimicrobial stewardship: systems and processes for effective antimicrobial medicine use’. (last accessed 28 February, 2018). <a target=xrefwindow id=d22208e973 href="https://www.nice.org.uk/guidance/ng15">Reference Source</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d22208e982 class=n-a></a>Seemungal T, Harper-Owen R, Bhowmik A, <i> et al.</i>: Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2001; <b>164</b>(9): 1618–23. <a target=xrefwindow id=d22208e993 href="http://www.ncbi.nlm.nih.gov/pubmed/11719299">PubMed Abstract </a> | <a target=xrefwindow id=d22208e996 href="http://dx.doi.org/10.1164/ajrccm.164.9.2105011">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725633406"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1005 class=n-a></a>Jain S, Self WH, Wunderink RG, <i> et al.</i>: Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. <i>N Engl J Med.</i> 2015; <b>373</b>(5): 415–27. <a target=xrefwindow id=d22208e1016 href="http://www.ncbi.nlm.nih.gov/pubmed/26172429">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1019 href="http://dx.doi.org/10.1056/NEJMoa1500245">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1023 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4728150">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725633406">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d22208e1036 class=n-a></a>Aabenhus R, Jensen JU, Jørgensen KJ, <i> et al.</i>: Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. <i>Cochrane Database Syst Rev.</i> 2014; (11): CD010130. <a target=xrefwindow id=d22208e1044 href="http://www.ncbi.nlm.nih.gov/pubmed/25374293">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1047 href="http://dx.doi.org/10.1002/14651858.CD010130.pub2">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d22208e1056 class=n-a></a>Woodhead M, Blasi F, Ewig S, <i> et al.</i>: Guidelines for the management of adult lower respiratory tract infections--summary. <i>Clin Microbiol Infect.</i> 2011; <b>17 Suppl 6</b>: 1–24. <a target=xrefwindow id=d22208e1067 href="http://www.ncbi.nlm.nih.gov/pubmed/21951384">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1070 href="http://dx.doi.org/10.1111/j.1469-0691.2011.03602.x">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731978812"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1080 class=n-a></a>Schuetz P, Wirz Y, Sager R, <i> et al.</i>: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. <i>Cochrane Database Syst Rev.</i> 2017; <b>10</b>: CD007498. <a target=xrefwindow id=d22208e1091 href="http://www.ncbi.nlm.nih.gov/pubmed/29025194">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1094 href="http://dx.doi.org/10.1002/14651858.CD007498.pub3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731978812">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732006388"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1107 class=n-a></a>Schuetz P, Wirz Y, Sager R, <i> et al.</i>: Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. <i>Lancet Infect Dis.</i> 2018; <b>18</b>(1): 95–107. <a target=xrefwindow id=d22208e1118 href="http://www.ncbi.nlm.nih.gov/pubmed/29037960">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1121 href="http://dx.doi.org/10.1016/S1473-3099(17)30592-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732006388">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733260904"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1134 class=n-a></a>Huang DT, Yealy DM, Filbin MR, <i> et al.</i>: Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection. <i>N Engl J Med.</i> 2018. <a target=xrefwindow id=d22208e1142 href="http://www.ncbi.nlm.nih.gov/pubmed/29781385">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1145 href="http://dx.doi.org/10.1056/NEJMoa1802670">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733260904">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d22208e1158 class=n-a></a>Mandell LA, Wunderink RG, Anzueto A, <i> et al.</i>: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. <i>Clin Infect Dis.</i> 2007; <b>44 Suppl 2</b>: S27–72. <a target=xrefwindow id=d22208e1169 href="http://www.ncbi.nlm.nih.gov/pubmed/17278083">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1172 href="http://dx.doi.org/10.1086/511159">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d22208e1181 class=n-a></a>Boyles TH, Brink A, Calligaro GL, <i> et al.</i>: South African guideline for the management of community-acquired pneumonia in adults. <i>J Thorac Dis.</i> 2017; <b>9</b>(6): 1469–502. <a target=xrefwindow id=d22208e1192 href="http://www.ncbi.nlm.nih.gov/pubmed/28740661">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1195 href="http://dx.doi.org/10.21037/jtd.2017.05.31">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1199 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5506119">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d22208e1208 class=n-a></a>Woodhead M, Noor M: Empirical antibiotic management of adult CAP. In: Chalmers JD, Pletz MW, Aliberti S, editors. <i>Community-Acquired Pneumonia</i>. European Respiratory Society; 2014; 140–154. <a target=xrefwindow id=d22208e1213 href="http://dx.doi.org/10.1183/1025448x.10004013">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d22208e1223 class=n-a></a>Torres A, Blasi F, Peetermans WE, <i> et al.</i>: The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. <i>Eur J Clin Microbiol Infect Dis.</i> 2014; <b>33</b>(7): 1065–79. <a target=xrefwindow id=d22208e1234 href="http://www.ncbi.nlm.nih.gov/pubmed/24532008">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1237 href="http://dx.doi.org/10.1007/s10096-014-2067-1">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1241 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4042014">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d22208e1250 class=n-a></a>Pakhale S, Mulpuru S, Verheij TJ, <i> et al.</i>: Antibiotics for community-acquired pneumonia in adult outpatients. <i>Cochrane Database Syst Rev.</i> 2014; (10): CD002109. <a target=xrefwindow id=d22208e1258 href="http://www.ncbi.nlm.nih.gov/pubmed/25300166">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1261 href="http://dx.doi.org/10.1002/14651858.CD002109.pub4">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d22208e1270 class=n-a></a>Bender MT, Niederman MS: Principles of Antibiotic Management of Community-Acquired Pneumonia. <i>Semin Respir Crit Care Med.</i> 2016; <b>37</b>(6): 905–12. <a target=xrefwindow id=d22208e1278 href="http://www.ncbi.nlm.nih.gov/pubmed/27960214">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1281 href="http://dx.doi.org/10.1055/s-0036-1592133">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d22208e1290 class=n-a></a>Waterer G: Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please! <i>Respirology.</i> 2018; <b>23</b>(5): 450–1. <a target=xrefwindow id=d22208e1298 href="http://www.ncbi.nlm.nih.gov/pubmed/29278281">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1301 href="http://dx.doi.org/10.1111/resp.13248">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/721524555"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1310 class=n-a></a>Garin N, Genné D, Carballo S, <i> et al.</i>: β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. <i>JAMA Intern Med.</i> 2014; <b>174</b>(12): 1894–901. <a target=xrefwindow id=d22208e1321 href="http://www.ncbi.nlm.nih.gov/pubmed/25286173">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1324 href="http://dx.doi.org/10.1001/jamainternmed.2014.4887">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/721524555">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725416065"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1337 class=n-a></a>Postma DF, van Werkhoven CH, van Elden LJ, <i> et al.</i>: Antibiotic treatment strategies for community-acquired pneumonia in adults. <i>N Engl J Med.</i> 2015; <b>372</b>(14): 1312–23. <a target=xrefwindow id=d22208e1348 href="http://www.ncbi.nlm.nih.gov/pubmed/25830421">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1351 href="http://dx.doi.org/10.1056/NEJMoa1406330">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725416065">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732299554"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1365 class=n-a></a>Okumura J, Shindo Y, Takahashi K, <i> et al.</i>: Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy. <i>Respirology.</i> 2018; <b>23</b>(5): 526–34. <a target=xrefwindow id=d22208e1376 href="http://www.ncbi.nlm.nih.gov/pubmed/29239493">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1379 href="http://dx.doi.org/10.1111/resp.13232">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732299554">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718218587"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1392 class=n-a></a>Gattarello S, Borgatta B, Solé-Violán J, <i> et al.</i>: Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013). <i>Chest.</i> 2014; <b>146</b>(1): 22–31. <a target=xrefwindow id=d22208e1403 href="http://www.ncbi.nlm.nih.gov/pubmed/24371840">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1406 href="http://dx.doi.org/10.1378/chest.13-1531">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718218587">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725788310"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1419 class=n-a></a>Gattarello S, Lagunes L, Vidaur L, <i> et al.</i>: Improvement of antibiotic therapy and ICU survival in severe non-pneumococcal community-acquired pneumonia: a matched case-control study. <i>Crit Care.</i> 2015; <b>19</b>: 335. <a target=xrefwindow id=d22208e1430 href="http://www.ncbi.nlm.nih.gov/pubmed/26369551">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1433 href="http://dx.doi.org/10.1186/s13054-015-1051-1">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1437 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4570589">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725788310">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727720228"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1450 class=n-a></a>Rahmel T, Asmussen S, Karlik J, <i> et al.</i>: Moxifloxacin monotherapy versus combination therapy in patients with severe community-acquired pneumonia evoked ARDS. <i>BMC Anesthesiol.</i> 2017; <b>17</b>(1): 78. <a target=xrefwindow id=d22208e1461 href="http://www.ncbi.nlm.nih.gov/pubmed/28615012">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1464 href="http://dx.doi.org/10.1186/s12871-017-0376-5">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1468 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5471686">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727720228">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d22208e1481 class=n-a></a>Adrie C, Schwebel C, Garrouste-Orgeas M, <i> et al.</i>: Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance. <i>Crit Care.</i> 2013; <b>17</b>(6): R265. <a target=xrefwindow id=d22208e1492 href="http://www.ncbi.nlm.nih.gov/pubmed/24200097">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1495 href="http://dx.doi.org/10.1186/cc13095">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1499 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4056004">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727153047"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1508 class=n-a></a>Sakamoto Y, Yamauchi Y, Yasunaga H, <i> et al.</i>: Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation. <i>Respir Investig.</i> 2017; <b>55</b>(1): 39–44. <a target=xrefwindow id=d22208e1519 href="http://www.ncbi.nlm.nih.gov/pubmed/28012492">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1522 href="http://dx.doi.org/10.1016/j.resinv.2016.08.006">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727153047">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732543267"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1536 class=n-a></a>De la Calle C, Ternavasio-de la Vega HG, Morata L, <i> et al.</i>: Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis. <i>J Infect.</i> 2018; <b>76</b>(4): 342–7. <a target=xrefwindow id=d22208e1547 href="http://www.ncbi.nlm.nih.gov/pubmed/29360520">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1550 href="http://dx.doi.org/10.1016/j.jinf.2018.01.003">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732543267">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731185672"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1563 class=n-a></a>Pereira JM, Gonçalves-Pereira J, Ribeiro O, <i> et al.</i>: Impact of antibiotic therapy in severe community-acquired pneumonia: Data from the Infauci study. <i>J Crit Care.</i> 2018; <b>43</b>: 183–9. <a target=xrefwindow id=d22208e1574 href="http://www.ncbi.nlm.nih.gov/pubmed/28915392">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1577 href="http://dx.doi.org/10.1016/j.jcrc.2017.08.048">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731185672">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718154776"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1590 class=n-a></a>Sligl WI, Asadi L, Eurich DT, <i> et al.</i>: Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis. <i>Crit Care Med.</i> 2014; <b>42</b>(2): 420–32. <a target=xrefwindow id=d22208e1601 href="http://www.ncbi.nlm.nih.gov/pubmed/24158175">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1604 href="http://dx.doi.org/10.1097/CCM.0b013e3182a66b9b">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718154776">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d22208e1617 class=n-a></a>Raz-Pasteur A, Shasha D, Paul M: Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis. <i>Int J Antimicrob Agents.</i> 2015; <b>46</b>(3): 242–8. <a target=xrefwindow id=d22208e1625 href="http://www.ncbi.nlm.nih.gov/pubmed/26092096">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1628 href="http://dx.doi.org/10.1016/j.ijantimicag.2015.04.010">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726141549"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1637 class=n-a></a>Lee JS, Giesler DL, Gellad WF, <i> et al.</i>: Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review. <i>JAMA.</i> 2016; <b>315</b>(6): 593–602. <a target=xrefwindow id=d22208e1648 href="http://www.ncbi.nlm.nih.gov/pubmed/26864413">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1651 href="http://dx.doi.org/10.1001/jama.2016.0115">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726141549">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726447139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1664 class=n-a></a>Horita N, Otsuka T, Haranaga S, <i> et al.</i>: Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: A systematic review and meta-analysis. <i>Respirology.</i> 2016; <b>21</b>(7): 1193–200. <a target=xrefwindow id=d22208e1675 href="http://www.ncbi.nlm.nih.gov/pubmed/27338144">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1678 href="http://dx.doi.org/10.1111/resp.12835">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726447139">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727066666"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1692 class=n-a></a>Lee JH, Kim HJ, Kim YH: Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis. <i>J Korean Med Sci.</i> 2017; <b>32</b>(1): 77–84. <a target=xrefwindow id=d22208e1700 href="http://www.ncbi.nlm.nih.gov/pubmed/27914135">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1703 href="http://dx.doi.org/10.3346/jkms.2017.32.1.77">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1706 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5143302">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727066666">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d22208e1719 class=n-a></a>Brown LA, Mitchell AM, Mitchell TJ: <i>Streptococcus pneumoniae</i> and lytic antibiotic therapy: are we adding insult to injury during invasive pneumococcal disease and sepsis? <i>J Med Microbiol.</i> 2017; <b>66</b>: 1253–1256. <a target=xrefwindow id=d22208e1730 href="http://www.ncbi.nlm.nih.gov/pubmed/28792379">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1733 href="http://dx.doi.org/10.1099/jmm.0.000545">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731389024"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1742 class=n-a></a>Metersky ML, Priya A, Mortensen EM, <i> et al.</i>: Association Between the Order of Macrolide and Cephalosporin Treatment and Outcomes of Pneumonia. <i>Open Forum Infect Dis.</i> 2017; <b>4</b>(3): ofx141. <a target=xrefwindow id=d22208e1753 href="http://www.ncbi.nlm.nih.gov/pubmed/28948176">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1756 href="http://dx.doi.org/10.1093/ofid/ofx141">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1760 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5597857">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731389024">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d22208e1773 class=n-a></a>Peyrani P, Wiemken TL, Metersky ML, <i> et al.</i>: The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. <i>Infect Dis (Lond).</i> 2018; <b>50</b>(1): 13–20. <a target=xrefwindow id=d22208e1784 href="http://www.ncbi.nlm.nih.gov/pubmed/28699429">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1787 href="http://dx.doi.org/10.1080/23744235.2017.1350881">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d22208e1796 class=n-a></a>Grossman RF, Hsueh PR, Gillespie SH, <i> et al.</i>: Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones. <i>Int J Infect Dis.</i> 2014; <b>18</b>: 14–21. <a target=xrefwindow id=d22208e1807 href="http://www.ncbi.nlm.nih.gov/pubmed/24211230">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1810 href="http://dx.doi.org/10.1016/j.ijid.2013.09.013">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d22208e1819 class=n-a></a>Low DE: Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective. <i>Clin Infect Dis.</i> 2009; <b>48</b>(10): 1361–3. <a target=xrefwindow id=d22208e1827 href="http://www.ncbi.nlm.nih.gov/pubmed/19348596">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1830 href="http://dx.doi.org/10.1086/598197">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d22208e1840 class=n-a></a>Marti C, John G, Genné D, <i> et al.</i>: Time to antibiotics administration and outcome in community-acquired pneumonia: Secondary analysis of a randomized controlled trial. <i>Eur J Intern Med.</i> 2017; <b>43</b>: 58–61. <a target=xrefwindow id=d22208e1851 href="http://www.ncbi.nlm.nih.gov/pubmed/28648477">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1854 href="http://dx.doi.org/10.1016/j.ejim.2017.06.012">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726765423"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1863 class=n-a></a>Rello J, Diaz E, Mañez R, <i> et al.</i>: Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case-control study. <i>Eur J Clin Microbiol Infect Dis.</i> 2017; <b>36</b>(1): 123–30. <a target=xrefwindow id=d22208e1874 href="http://www.ncbi.nlm.nih.gov/pubmed/27655267">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1877 href="http://dx.doi.org/10.1007/s10096-016-2779-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726765423">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726735142"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1890 class=n-a></a>Iroezindu MO, Isiguzo GC, Chima EI, <i> et al.</i>: Predictors of in-hospital mortality and length of stay in community-acquired pneumonia: a 5-year multi-centre case control study of adults in a developing country. <i>Trans R Soc Trop Med Hyg.</i> 2016; <b>110</b>(8): 445–55. <a target=xrefwindow id=d22208e1901 href="http://www.ncbi.nlm.nih.gov/pubmed/27618923">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1904 href="http://dx.doi.org/10.1093/trstmh/trw057">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726735142">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d22208e1917 class=n-a></a>Shaddock EJ, Feldman C: Shorter antibiotic courses in community-acquired pneumonia-ready for prime time. <i>J Thorac Dis.</i> 2016; <b>8</b>(12): E1628–E1631. <a target=xrefwindow id=d22208e1925 href="http://www.ncbi.nlm.nih.gov/pubmed/28149599">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1928 href="http://dx.doi.org/10.21037/jtd.2016.12.52">Publisher Full Text </a> | <a target=xrefwindow id=d22208e1931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5227268">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726574882"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1940 class=n-a></a>Uranga A, España PP, Bilbao A, <i> et al.</i>: Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial. <i>JAMA Intern Med.</i> 2016; <b>176</b>(9): 1257–65. <a target=xrefwindow id=d22208e1951 href="http://www.ncbi.nlm.nih.gov/pubmed/27455166">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1954 href="http://dx.doi.org/10.1001/jamainternmed.2016.3633">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726574882">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727784180"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e1967 class=n-a></a>Aliberti S, Ramirez J, Giuliani F, <i> et al.</i>: Individualizing duration of antibiotic therapy in community-acquired pneumonia. <i>Pulm Pharmacol Ther.</i> 2017; <b>45</b>: 191–201. <a target=xrefwindow id=d22208e1978 href="http://www.ncbi.nlm.nih.gov/pubmed/28666965">PubMed Abstract </a> | <a target=xrefwindow id=d22208e1981 href="http://dx.doi.org/10.1016/j.pupt.2017.06.008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727784180">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d22208e1995 class=n-a></a>Pinzone MR, Cacopardo B, Abbo L, <i> et al.</i>: Duration of antimicrobial therapy in community acquired pneumonia: less is more. <i>ScientificWorldJournal.</i> 2014; <b>2014</b>: 759138. <a target=xrefwindow id=d22208e2006 href="http://www.ncbi.nlm.nih.gov/pubmed/24578660">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2009 href="http://dx.doi.org/10.1155/2014/759138">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2013 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3918712">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727205127"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2022 class=n-a></a>Kaziani K, Sotiriou A, Dimopoulos G: Duration of pneumonia therapy and the role of biomarkers. <i>Curr Opin Infect Dis.</i> 2017; <b>30</b>(2): 221–5. <a target=xrefwindow id=d22208e2030 href="http://www.ncbi.nlm.nih.gov/pubmed/28079629">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2033 href="http://dx.doi.org/10.1097/QCO.0000000000000351">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727205127">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d22208e2046 class=n-a></a>Engel MF, Bruns AH, Hulscher ME, <i> et al.</i>: A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study. <i>Eur J Clin Microbiol Infect Dis.</i> 2014; <b>33</b>(11): 1897–908. <a target=xrefwindow id=d22208e2057 href="http://www.ncbi.nlm.nih.gov/pubmed/24859925">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2060 href="http://dx.doi.org/10.1007/s10096-014-2158-z">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d22208e2069 class=n-a></a>Marcos PJ, Restrepo MI, Sanjuàn P, <i> et al.</i>: Community-acquired pneumonia team decreases length of stay in hospitalized, low-risk patients with pneumonia. <i>Hosp Pract (1995).</i> 2013; <b>41</b>(3): 7–14. <a target=xrefwindow id=d22208e2080 href="http://www.ncbi.nlm.nih.gov/pubmed/23948616">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2083 href="http://dx.doi.org/10.3810/hp.2013.08.1063">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727105155"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2092 class=n-a></a>Sibila O, Rodrigo-Troyano A, Torres A: Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them? <i>Semin Respir Crit Care Med.</i> 2016; <b>37</b>(6): 913–22. <a target=xrefwindow id=d22208e2100 href="http://www.ncbi.nlm.nih.gov/pubmed/27960215">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2103 href="http://dx.doi.org/10.1055/s-0036-1593538">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727105155">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d22208e2116 class=n-a></a>Feldman C, Anderson R: Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials. <i>J Thorac Dis.</i> 2016; <b>8</b>(3): E162–71. <a target=xrefwindow id=d22208e2124 href="http://www.ncbi.nlm.nih.gov/pubmed/27076965">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2127 href="http://dx.doi.org/10.21037/jtd.2016.02.43">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2130 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4805802">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732292075"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2140 class=n-a></a>Stern A, Skalsky K, Avni T, <i> et al.</i>: Corticosteroids for pneumonia. <i>Cochrane Database Syst Rev.</i> 2017; <b>12</b>: CD007720. <a target=xrefwindow id=d22208e2151 href="http://www.ncbi.nlm.nih.gov/pubmed/29236286">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2154 href="http://dx.doi.org/10.1002/14651858.CD007720.pub3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732292075">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d22208e2167 class=n-a></a>Brink AJ, van Wyk J, Moodley VM, <i> et al.</i>: The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. <i>S Afr Med J.</i> 2016; <b>106</b>(6): 30–7. <a target=xrefwindow id=d22208e2178 href="http://www.ncbi.nlm.nih.gov/pubmed/27245715">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2181 href="http://dx.doi.org/10.7196/SAMJ.2016.v106i6.10857">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d22208e2190 class=n-a></a>Anthonisen NR, Manfreda J, Warren CP, <i> et al.</i>: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. <i>Ann Intern Med.</i> 1987; <b>106</b>(2): 196–204. <a target=xrefwindow id=d22208e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/3492164">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2204 href="http://dx.doi.org/10.7326/0003-4819-106-2-196">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d22208e2213 class=n-a></a>Allegra L, Blasi F, de Bernardi B, <i> et al.</i>: Antibiotic treatment and baseline severity of disease in acute exacerbations of chronic bronchitis: a re-evaluation of previously published data of a placebo-controlled randomized study. <i>Pulm Pharmacol Ther.</i> 2001; <b>14</b>(2): 149–55. <a target=xrefwindow id=d22208e2224 href="http://www.ncbi.nlm.nih.gov/pubmed/11273797">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2227 href="http://dx.doi.org/10.1006/pupt.2001.0289">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1697956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2236 class=n-a></a>Daniels JM, Snijders D, de Graaff CS, <i> et al.</i>: Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2010; <b>181</b>(2): 150–7. <a target=xrefwindow id=d22208e2247 href="http://www.ncbi.nlm.nih.gov/pubmed/19875685">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2250 href="http://dx.doi.org/10.1164/rccm.200906-0837OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1697956">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717955160"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2263 class=n-a></a>Llor C, Moragas A, Hernández S, <i> et al.</i>: Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2012; <b>186</b>(8): 716–23. <a target=xrefwindow id=d22208e2274 href="http://www.ncbi.nlm.nih.gov/pubmed/22923662">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2277 href="http://dx.doi.org/10.1164/rccm.201206-0996OC">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717955160">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d22208e2291 class=n-a></a>Miravitlles M, Moragas A, Hernández S, <i> et al.</i>: Is it possible to identify exacerbations of mild to moderate COPD that do not require antibiotic treatment? <i>Chest.</i> 2013; <b>144</b>(5): 1571–7. <a target=xrefwindow id=d22208e2302 href="http://www.ncbi.nlm.nih.gov/pubmed/23807094">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2305 href="http://dx.doi.org/10.1378/chest.13-0518">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726489123"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2314 class=n-a></a>Lin C, Pang Q: Meta-analysis and systematic review of procalcitonin-guided treatment in acute exacerbation of chronic obstructive pulmonary disease. <i>Clin Respir J.</i> 2018; <b>12</b>(1): 10–5. <a target=xrefwindow id=d22208e2322 href="http://www.ncbi.nlm.nih.gov/pubmed/27328801">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2325 href="http://dx.doi.org/10.1111/crj.12519">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726489123">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733626162"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2338 class=n-a></a>Ra SW, Kwon YS, Yoon SH, <i> et al.</i>: Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease. <i>Clin Respir J.</i> 2018; <b>12</b>(4): 1424–32. <a target=xrefwindow id=d22208e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/28756637">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2352 href="http://dx.doi.org/10.1111/crj.12671">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733626162">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d22208e2365 class=n-a></a>Miravitlles M, Murio C, Guerrero T: Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group. <i>Eur Respir J.</i> 2001; <b>17</b>(5): 928–33. <a target=xrefwindow id=d22208e2373 href="http://www.ncbi.nlm.nih.gov/pubmed/11488328">PubMed Abstract </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d22208e2382 class=n-a></a>Wilson R, Jones P, Schaberg T, <i> et al.</i>: Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. <i>Thorax.</i> 2006; <b>61</b>(4): 337–42. <a target=xrefwindow id=d22208e2393 href="http://www.ncbi.nlm.nih.gov/pubmed/16449273">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2396 href="http://dx.doi.org/10.1136/thx.2005.045930">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2400 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2104610">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d22208e2409 class=n-a></a>Sethi S, Murphy TF: Infection in the pathogenesis and course of chronic obstructive pulmonary disease. <i>N Engl J Med.</i> 2008; <b>359</b>(22): 2355–65. <a target=xrefwindow id=d22208e2417 href="http://www.ncbi.nlm.nih.gov/pubmed/19038881">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2420 href="http://dx.doi.org/10.1056/NEJMra0800353">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d22208e2430 class=n-a></a>Sharan H: Aerobic Bacteriological Study of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. <i>J Clin Diagn Res.</i> 2015; <b>9</b>(8): DC10–2. <a target=xrefwindow id=d22208e2438 href="http://www.ncbi.nlm.nih.gov/pubmed/26435942">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2441 href="http://dx.doi.org/10.7860/JCDR/2015/14515.6367">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2444 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4576533">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d22208e2453 class=n-a></a>Narayanagowda D, Golia S, Jaiswal J, <i> et al.</i>: A bacteriological study of acute exacerbation of chronic obstructive pulmonary disease over a period of one year. <i>Int J Res Med Sci.</i> 2015; <b>3</b>(11): 3141–6. <a target=xrefwindow id=d22208e2464 href="http://dx.doi.org/10.18203/2320-6012.ijrms20151152">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732667303"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2473 class=n-a></a>Kuwal A, Joshi V, Dutt N, <i> et al.</i>: A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure. <i>Turk Thorac J.</i> 2018; <b>19</b>(1): 19–27. <a target=xrefwindow id=d22208e2484 href="http://www.ncbi.nlm.nih.gov/pubmed/29404182">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2487 href="http://dx.doi.org/10.5152/TurkThoracJ.2017.17035">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2491 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5783049">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732667303">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726439009"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2504 class=n-a></a>Rodrigo-Troyano A, Suarez-Cuartin G, Peiró M, <i> et al.</i>: <i>Pseudomonas aeruginosa</i> resistance patterns and clinical outcomes in hospitalized exacerbations of COPD. <i>Respirology.</i> 2016; <b>21</b>(7): 1235–42. <a target=xrefwindow id=d22208e2518 href="http://www.ncbi.nlm.nih.gov/pubmed/27325555">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2522 href="http://dx.doi.org/10.1111/resp.12825">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726439009">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d22208e2535 class=n-a></a>Nakou A, Papaparaskevas J, Diamantea F, <i> et al.</i>: A prospective study on bacterial and atypical etiology of acute exacerbation in chronic obstructive pulmonary disease. <i>Future Microbiol.</i> 2014; <b>9</b>(11): 1251–60. <a target=xrefwindow id=d22208e2546 href="http://www.ncbi.nlm.nih.gov/pubmed/25437187">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2549 href="http://dx.doi.org/10.2217/fmb.14.90">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d22208e2558 class=n-a></a>FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. (last accessed 27 February 2018). <a target=xrefwindow id=d22208e2560 href="https://www.fda.gov/Drugs/DrugSafety/ucm511530.htm">Reference Source</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d22208e2570 class=n-a></a>Miravitlles M, Soler-Cataluña JJ, Calle M, <i> et al.</i>: Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase. <i>Arch Bronconeumol.</i> 2017; <b>53</b>(6): 324–35. <a target=xrefwindow id=d22208e2581 href="http://www.ncbi.nlm.nih.gov/pubmed/28477954">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2584 href="http://dx.doi.org/10.1016/j.arbres.2017.03.018">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732300287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2593 class=n-a></a>Stolbrink M, Amiry J, Blakey JD: Does antibiotic treatment duration affect the outcomes of exacerbations of asthma and COPD? A systematic review. <i>Chron Respir Dis.</i> 2017; 1479972317745734. <a target=xrefwindow id=d22208e2598 href="http://www.ncbi.nlm.nih.gov/pubmed/29232988">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2601 href="http://dx.doi.org/10.1177/1479972317745734">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732300287">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727847409"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2614 class=n-a></a>Llewelyn MJ, Fitzpatrick JM, Darwin E, <i> et al.</i>: The antibiotic course has had its day. <i>BMJ.</i> 2017; <b>358</b>: j3418. <a target=xrefwindow id=d22208e2625 href="http://www.ncbi.nlm.nih.gov/pubmed/28747365">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2628 href="http://dx.doi.org/10.1136/bmj.j3418">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727847409">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d22208e2641 class=n-a></a>Falagas ME, Avgeri SG, Matthaiou DK, <i> et al.</i>: Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. <i>J Antimicrob Chemother.</i> 2008; <b>62</b>(3): 442–50. <a target=xrefwindow id=d22208e2652 href="http://www.ncbi.nlm.nih.gov/pubmed/18467303">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2655 href="http://dx.doi.org/10.1093/jac/dkn201">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d22208e2664 class=n-a></a>El Moussaoui R, Roede BM, Speelman P, <i> et al.</i>: Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. <i>Thorax.</i> 2008; <b>63</b>(5): 415–22. <a target=xrefwindow id=d22208e2675 href="http://www.ncbi.nlm.nih.gov/pubmed/18234905">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2678 href="http://dx.doi.org/10.1136/thx.2007.090613">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d22208e2687 class=n-a></a>Drusano GL: From lead optimization to NDA approval for a new antimicrobial: Use of pre-clinical effect models and pharmacokinetic/pharmacodynamic mathematical modeling. <i>Bioorg Med Chem.</i> 2016; <b>24</b>(24): 6401–8. <a target=xrefwindow id=d22208e2695 href="http://www.ncbi.nlm.nih.gov/pubmed/27612961">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2698 href="http://dx.doi.org/10.1016/j.bmc.2016.08.034">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d22208e2708 class=n-a></a>Drusano GL, Louie A, MacGowan A, <i> et al.</i>: Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1. <i>Antimicrob Agents Chemother.</i> 2015; <b>60</b>(3): 1183–93. <a target=xrefwindow id=d22208e2719 href="http://www.ncbi.nlm.nih.gov/pubmed/26711759">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2722 href="http://dx.doi.org/10.1128/AAC.02177-15">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2726 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4775960">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732379782"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2735 class=n-a></a>Lipari M, Smith AL, Kale-Pradhan PB, <i> et al.</i>: Adherence to GOLD Guidelines in the Inpatient COPD Population. <i>J Pharm Pract.</i> 2018; <b>31</b>(1): 29–33. <a target=xrefwindow id=d22208e2746 href="http://www.ncbi.nlm.nih.gov/pubmed/29278993">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2749 href="http://dx.doi.org/10.1177/0897190017696949">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732379782">F1000 Recommendation</a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d22208e2762 class=n-a></a>Dal Negro R, Micheletto C, Tognella S, <i> et al.</i>: Tobramycin Nebulizer Solution in severe COPD patients colonized with <i>Pseudomonas aeruginosa</i>: effects on bronchial inflammation. <i>Adv Ther.</i> 2008; <b>25</b>(10): 1019–30. <a target=xrefwindow id=d22208e2776 href="http://www.ncbi.nlm.nih.gov/pubmed/18821068">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2780 href="http://dx.doi.org/10.1007/s12325-008-0105-2">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d22208e2789 class=n-a></a>Wedzicha JA, Singh R, Mackay AJ: Acute COPD exacerbations. <i>Clin Chest Med.</i> 2014; <b>35</b>(1): 157–63. <a target=xrefwindow id=d22208e2797 href="http://www.ncbi.nlm.nih.gov/pubmed/24507843">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2800 href="http://dx.doi.org/10.1016/j.ccm.2013.11.001">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d22208e2809 class=n-a></a>Yamaya M, Azuma A, Takizawa H, <i> et al.</i>: Macrolide effects on the prevention of COPD exacerbations. <i>Eur Respir J.</i> 2012; <b>40</b>(2): 485–94. <a target=xrefwindow id=d22208e2820 href="http://www.ncbi.nlm.nih.gov/pubmed/22408201">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2823 href="http://dx.doi.org/10.1183/09031936.00208011">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d22208e2832 class=n-a></a>Donath E, Chaudhry A, Hernandez-Aya LF, <i> et al.</i>: A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease. <i>Respir Med.</i> 2013; <b>107</b>(9): 1385–92. <a target=xrefwindow id=d22208e2843 href="http://www.ncbi.nlm.nih.gov/pubmed/23768735">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2846 href="http://dx.doi.org/10.1016/j.rmed.2013.05.004">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718363388"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2856 class=n-a></a>Uzun S, Djamin RS, Kluytmans JA, <i> et al.</i>: Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial. <i>Lancet Respir Med.</i> 2014; <b>2</b>(5): 361–8. <a target=xrefwindow id=d22208e2867 href="http://www.ncbi.nlm.nih.gov/pubmed/24746000">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2870 href="http://dx.doi.org/10.1016/S2213-2600(14)70019-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718363388">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d22208e2883 class=n-a></a>Parameswaran GI, Sethi S: Long-term macrolide therapy in chronic obstructive pulmonary disease. <i>CMAJ.</i> 2014; <b>186</b>(15): 1148–52. <a target=xrefwindow id=d22208e2891 href="http://www.ncbi.nlm.nih.gov/pubmed/25096664">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2894 href="http://dx.doi.org/10.1503/cmaj.121573">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2897 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4203601">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d22208e2906 class=n-a></a>Spagnolo P, Fabbri LM, Bush A: Long-term macrolide treatment for chronic respiratory disease. <i>Eur Respir J.</i> 2013; <b>42</b>(1): 239–51. <a target=xrefwindow id=d22208e2914 href="http://www.ncbi.nlm.nih.gov/pubmed/23180583">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2917 href="http://dx.doi.org/10.1183/09031936.00136712">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d22208e2926 class=n-a></a>Simoens S, Laekeman G, Decramer M: Preventing COPD exacerbations with macrolides: a review and budget impact analysis. <i>Respir Med.</i> 2013; <b>107</b>(5): 637–48. <a target=xrefwindow id=d22208e2934 href="http://www.ncbi.nlm.nih.gov/pubmed/23352223">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2937 href="http://dx.doi.org/10.1016/j.rmed.2012.12.019">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d22208e2946 class=n-a></a>Gilchrist SA, Nanni A, Levine O: Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. <i>Am J Public Health.</i> 2012; <b>102</b>(4): 596–605. <a target=xrefwindow id=d22208e2954 href="http://www.ncbi.nlm.nih.gov/pubmed/22397339">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2957 href="http://dx.doi.org/10.2105/AJPH.2011.300512">Publisher Full Text </a> | <a target=xrefwindow id=d22208e2960 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3489371">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727733237"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22208e2969 class=n-a></a>Teo E, Lockhart K, Purchuri SN, <i> et al.</i>: <i>Haemophilus influenzae</i> oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. <i>Cochrane Database Syst Rev.</i> 2017; <b>6</b>: CD010010. <a target=xrefwindow id=d22208e2983 href="http://www.ncbi.nlm.nih.gov/pubmed/28626902">PubMed Abstract </a> | <a target=xrefwindow id=d22208e2987 href="http://dx.doi.org/10.1002/14651858.CD010010.pub3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727733237">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1121/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1121/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa<br/> <sup>2</sup> Division of Critical Care, Charlotte Maxeke Johannesburg Academic Hospital, and Faculty of Health Sciences, University of Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa<br/> <p> <div class=margin-bottom> Charles Feldman <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Guy Richards <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1121/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 23 Jul 2018, 7:1121 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14226.1">https://doi.org/10.12688/f1000research.14226.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Feldman C and Richards G. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=15478 data-id=14226 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14226.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1121/v1/pdf?article_uuid=a0795424-ed12-4c87-903d-feecdb455b4c" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14226.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Feldman C and Richards G. Appropriate antibiotic management of bacterial lower respiratory tract infections [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1121 (<a href="https://doi.org/10.12688/f1000research.14226.1" target=_blank>https://doi.org/10.12688/f1000research.14226.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14226 id=mobile-track-article-signin-14226 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14226?target=/articles/7-1121/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=15478 /> <input name=articleId type=hidden value=14226 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Lars Bjerrum</strong>, Section of General Practice and Research Unit for General Practice, Department of Public Health, University of Copenhagen, Denmark </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Carles Llor</strong>, Primary Care Centre Via Roma, Spain </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>David SC Hui</strong>, Department of Medicine and Therapeutics, Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, China </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 23 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1121/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1121/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=36652-36130></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=36653-36129></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1121/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>23 Jul 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Lars Bjerrum</strong>, Section of General Practice and Research Unit for General Practice, Department of Public Health, University of Copenhagen, Denmark </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Carles Llor</strong>, Primary Care Centre Via Roma, Spain </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>David SC Hui</strong>, Department of Medicine and Therapeutics, Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, China </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1121/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1121/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Appropriate antibiotic management of bacterial...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1121/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1121/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1121/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Feldman C and Richards G');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1121/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1121",
            templates : {
                twitter : "Appropriate antibiotic management of bacterial lower respiratory.... Feldman C and Richards G, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1121/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Appropriate antibiotic management of bacterial lower respiratory tract infections", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Appropriate antibiotic management of bacterial lower respiratory tract infections", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14226/15478")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "15478");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "36129": 0,
                           "36130": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "417d6f7e-df46-4858-bc55-4bb33c591510";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1121.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1121.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1121.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1121.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1121.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>